Loulla & Philla
Loulla & Philla is a European project funded by the European Commission through the 7th Framework Programme for Research and Development.
The aim of the project is the development of 6-mercaptopurine and Methotrexate oral liquid formulations for the maintenance treatment of Acute Lymphoblastic Leukemia in children.
The project coordinated by the French SME Only for Children Pharmaceuticals gathers 9 partners and began last 1st November 2008 for 36 months duration.

